SET welcomes listing of Nakornthon Hospital (NKT) on December 20

NKT operates its 150-bed tertiary care facility, known as Nakornthon Hospital, with more than 28 years of operational and medical excellence. The hospital has established itself as a comprehensive medical hub through its extensive network of departments, including internal medicine, and 20 specialized centers such as neurology center, heart center, and cancer center. Each facility is equipped with advanced medical technologies and staffed by multidisciplinary teams of experienced medical professionals. Through its strategic partnership with Bamrungrad Hospital's healthcare network in western Bangkok's Rama II area, Nakornthon Hospital continues to expand its reach and reinforce its reputation as a trusted healthcare provider in the region.

NKT has a paid-up capital of THB 535 million with a par value of THB 1 per share. The company offered a total of 135 million IPO shares at THB 7.80 per share, raising a total of THB 1.05 billion (approximately USD 122.93 million). The IPO offering was structured in two phases: the first phase from December 2-4, 2024 and the second phase from December 9 and 11-12, 2024. During the first phase, approximately 67.50 million shares were allocated to subscribers at the underwriters' discretion, approximately 20.25 million shares to patrons of the company and its subsidiaries, and approximately 13.50 million shares to the company's related parties and employees of the company and its subsidiaries. In the second phase, approximately 33.75 million shares were allocated to institutional investors. Siam Commercial Bank pcl and Trinity Securities Co., Ltd. are the financial advisors and InnovestX Securities Co., Ltd. and Trinity Securities Co., Ltd. are the co-lead underwriters.

NKT Chief Executive Officer Dr. Wisan Saipetch emphasized Nakornthon Hospital's unique position as a prominent one-stop healthcare service provider in an area that is poised for future urban development. The IPO funds will accelerate the company's strategic expansion of its healthcare business, including bed capacity enhancement and new investment projects, with a particular focus on serving patients under Social Security Fund program and developing a comprehensive geriatric and long-term care center. These developments align with NKT's aspiration to broaden its service spectrum and cement its position among Thailand's healthcare leaders.

NKT's top three shareholders after the IPO are the Thongsima family (41.46 percent), Kate Saipetch's group (11.87 percent), and Virach Anantachai (1.41 percent). The IPO price, determined through the book-building process, represents the price-to-earnings (P/E) ratio of 17.60 times. The earnings per share is equivalent to THB 0.44, calculated from the company's net profit over the last 12 months (from October 1, 2023 to September 30, 2024), divided by fully diluted shares. The company's dividend policy is to pay shareholders a minimum of 40 percent of its net profit based on the separate financial statements after corporate income tax, all legally mandated reserves, and other provisions as stipulated in the company's bylaws.

For more information on NKT, please see the company's prospectus at the Securities and Exchange Commission's website at www.sec.or.th, and general information on www.nakornthon.com and www.set.or.th.

• ข่าวo:editor
• ข่าวo:fin
• ข่าวo:loc
• ข่าวen